fosinopril has been researched along with Cardiomegaly in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burrell, LM; Cooper, ME; Jaworski, K; Kubota, E; Mifsud, SA; Wilkinson-Berka, JL | 1 |
| Gao, J; He, H; Ma, L; Wang, P; Wang, W; Wu, H; Zhang, H | 1 |
| Aurigemma, GP; Douglas, PS; Katz, SE; Litwin, SE; Lorell, BH; Weinberg, EO | 1 |
| Beschi, M; Bettoni, G; Böhm, M; Castellano, M; Cinelli, A; Porteri, E; Rizzoni, D; Rosei, EA | 1 |
| Barry, WH; Gwathmey, JK; Hajjar, RJ; Kagaya, Y; Lorell, BH | 1 |
| Fu, J; Kim, L; Lee, T; Ritchie, ME | 1 |
6 other study(ies) available for fosinopril and Cardiomegaly
| Article | Year |
|---|---|
Cardiorenal protective effects of vasopeptidase inhibition with omapatrilat in hypertensive transgenic (mREN-2)27 rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Body Weight; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; Fosinopril; Hypertension; Kidney; Male; Models, Cardiovascular; Neprilysin; Pyridines; Rats; Renin; Statistics as Topic; Survival Analysis; Systole; Thiazepines; Time Factors; Treatment Outcome | 2004 |
Fosinopril and carvedilol reverse hypertrophy and change the levels of protein kinase C epsilon and components of its signaling complex.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Carbazoles; Cardiomegaly; Carvedilol; Fosinopril; Heart Failure; Lung; Male; Myocardium; Propanolamines; Protein Kinase C-epsilon; Proteomics; Rats; Rats, Sprague-Dawley; Signal Transduction | 2006 |
Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Diastole; Echocardiography; Fosinopril; Heart Failure; Hemodynamics; Hypertension; Male; Rats; Rats, Wistar; Systole; Time Factors; Ventricular Function, Left | 1995 |
Chronic ACE-inhibitor treatment and adrenergic mechanisms in spontaneously hypertensive rats.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Fosinopril; Hypertension; Mesenteric Arteries; Myocardium; Norepinephrine; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Ribonucleases; RNA, Messenger; Synaptic Transmission; Vascular Resistance | 1995 |
Long-term angiotensin-converting enzyme inhibition with fosinopril improves depressed responsiveness to Ca2+ in myocytes from aortic-banded rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Calcium; Cardiac Output, Low; Cardiomegaly; Constriction; Fosinopril; Heart; Hypertension; Male; Myocardial Contraction; Myocardium; Rats; Rats, Wistar; Time Factors | 1996 |
Characterization of MAP kinase and PKC isoform and effect of ACE inhibition in hypertrophy in vivo.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiomegaly; Enzyme Activation; Fosinopril; Hydralazine; Hypertension; Isoenzymes; Mitogen-Activated Protein Kinases; Nuclear Proteins; Phosphoproteins; Protein Kinase C; Rats; Rats, Sprague-Dawley; Response Elements; Transfection | 1999 |